Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

(2015) Susan Hariri et al.   VACCINE

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study

(2015) Eva Herweijer et al.   PLoS One

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial

(2014) Xavier Castellsagué et al.   BMC INFECTIOUS DISEASES

50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence

(2014) S Vaccarella et al.   BRITISH JOURNAL OF CANCER

Effectiveness of the Quadrivalent Human Papillomavirus Vaccine Against Cervical Dysplasia in Manitoba, Canada

(2014) Salaheddin M. Mahmud et al.   JOURNAL OF CLINICAL ONCOLOGY

Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women

(2014) B. Baldur-Felskov et al.   JNCI-Journal of the National Cancer Institute

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia

(2014) E. Crowe et al.   BMJ-British Medical Journal

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

(2013) Dorota M Gertig et al.   BMC Medicine

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study

(2013) Amy Leval et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions

(2012) Suzanne E. Powell et al.   VACCINE

Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination

(2011) KIRSTEN EGEBJERG JENSEN et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3

(2011) L. Baandrup et al.   GYNECOLOGIC ONCOLOGY

Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection

(2011) Richard M. Haupt et al.   INTERNATIONAL JOURNAL OF CANCER

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions

(2009) S Brismar-Wendel et al.   BRITISH JOURNAL OF CANCER

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

The completeness of the Swedish Cancer Register – a sample survey for year 1998

(2008) Lotti Barlow et al.   ACTA ONCOLOGICA

Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner

(2008) Rachel L. Winer et al.   JOURNAL OF INFECTIOUS DISEASES